AILBRY - Article Search
Serach over 250 million academic articles from all areas of study
Results for 'Baiyong Li'
:
Abstract 5526: AK131, an anti-PD1/CD73 bispecific antibody for cancer immune therapy
Publication Year: 2022
DOI: https://doi.org/10.1158/1538-7445.am2022-5526
Abstract:
Add to Library
Authors:
Zhaoliang Huang
Xinghua Pang
Tingting Zhong
Chunshan Jin
Na Chen
Dennis Xia
Peng Zhang
Max Wang
Michelle Xia
Baiyong Li
Abstract 3827: Bispecific antibodies with an anti-PD-1 backbone for cancer therapy generate enhanced immune activity
Publication Year: 2018
DOI: https://doi.org/10.1158/1538-7445.am2018-3827
Abstract:
Add to Library
Authors:
Baiyong Li
Zhaoliang Huang
Xinghua Pang
Tingting Zhong
Na Chen
Max Wang
Xiaoping Jin
Dennis Xia
Peng Zhang
Michelle Xia
Cutting Edge: Chemoattractant Receptor-Homologous Molecule Expressed on TH2 Cells Plays a Restricting Role on IL-5 Production and Eosinophil Recruitment
Publication Year: 2005
DOI: https://doi.org/10.4049/jimmunol.175.4.2056
Abstract:
Add to Library
Authors:
Éric Chevalier
Jeff Stock
Timothy S. Fisher
Mathieu Dupont
Magali Fric
Helene Fargeau
Murielle Leport
Sylvain Soler
Fabien Schmidlin
Marie‐Pierre Pruniaux
Michel Fink
Claude Bertrand
John A. McNeish
Baiyong Li
Abstract 5520: AK129, an anti-PD1/LAG-3 bi-specific antibody for cancer therapy
Publication Year: 2022
DOI: https://doi.org/10.1158/1538-7445.am2022-5520
Abstract:
Add to Library
Authors:
Zhaoliang Huang
Xinghua Pang
Tingting Zhong
Chunshan Jin
Na Chen
Dennis Xia
Peng Zhang
Max Wang
Michelle Xia
Baiyong Li
Abstract 5180: A randomized, double-blind, placebo-controlled phase III study to evaluate AK104 plus platinum-containing chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer
Publication Year: 2022
DOI: https://doi.org/10.1158/1538-7445.am2022-5180
Abstract:
Add to Library
Authors:
Xiaohua Wu
Jing Wang
Yi Huang
Yuzhi Li
Yang Sun
Ke Wang
Michelle Xia
Baiyong Li
Wei Liu
Abstract B123: Mechanism of action of ivonescimab (AK112/SMT112): a first-in-class tetravalent Fc-silent bispecific antibody with dual blockade of PD-1 and VEGF that promotes cooperative biological effects
Publication Year: 2023
DOI: https://doi.org/10.1158/1535-7163.targ-23-b123
Abstract:
Add to Library
Authors:
Tingting Zhong
Zhaoliang Huang
Xinghua Pang
Chunshan Jin
Xinrong He
José G. Montoya
Betty Chang
Michelle Xia
Baiyong Li
Min Jing
Woman Writing about Women: Li Shuyi's (1817-?) Project on One Hundred Beauties in Chinese History
Publication Year: 2011
DOI: https://doi.org/10.1163/156852611x559349
Abstract:
Add to Library
Authors:
Robotic approach improves spleen-preserving rate and shortens postoperative hospital stay of laparoscopic distal pancreatectomy: a matched cohort study
Publication Year: 2015
DOI: https://doi.org/10.1007/s00464-015-4101-5
Abstract:
Add to Library
Authors:
Shi Chen
Qian Zhan
Jiang-Zhi Chen
Jiabin Jin
Xiaxing Deng
Hao Chen
Baiyong Shen
Chenghong Peng
Hongwei Li
Toward a New Legal Realism
Publication Year: 2001
DOI: https://doi.org/10.2307/1600448
Abstract:
Add to Library
Authors:
Daniel A. Farber
Cass R. Sunstein
384 A Phase 1 study to evaluate the safety, PK, and antitumor activity of AK117, an anti-CD47 monoclonal antibody, in subjects with relapsed/refractory advanced or metastatic solid tumors or lymphomas
Publication Year: 2020
DOI: https://doi.org/10.1136/jitc-2020-sitc2020.0384
Abstract:
Add to Library
Authors:
Amy Prawira
Jermaine Coward
Anna Rachelle Mislang
Adnan Nagrial
Hui Gan
Xiaoping Jin
Baiyong Li
Zhongmin Maxwell Wang
Kon Yew Kwek
Dennis Xia
Yu Xia
China: Labour Reform and the Challenge Facing the Working Class
Publication Year: 1997
DOI: https://doi.org/10.1177/030981689706100104
Abstract:
Add to Library
Authors:
Late Pleistocene and Holocene loess sedimentation in central and western Qilian Shan (China) revealed by OSL dating
Publication Year: 2015
DOI: https://doi.org/10.1016/j.quaint.2014.12.054
Abstract:
Add to Library
Authors:
Jingran Zhang
Veit Nottebaum
Sumiko Tsukamoto
Frank Lehmkuhl
Manfred Frechen
Abstract LB098: Combination of a PD-1/CTLA-4 bispecific antibody with orally active PD-L1 inhibitor MAX-10181 effectively increased the percentage of tumors inhibited in animal model study
Publication Year: 2023
DOI: https://doi.org/10.1158/1538-7445.am2023-lb098
Abstract:
Add to Library
Authors:
Yuguang Wang
Yuan Gao
Chenyu Mao
Nong Xu
Qiang Zhang
Jing Wang
Zhenhua Feng
Yonghong Zhu
Zhongmin Wang
Baiyong Li
Abstract 5524: AK127, a novel monoclonal antibody (mAb) targeting T cell immunoreceptor (TIGIT)
Publication Year: 2022
DOI: https://doi.org/10.1158/1538-7445.am2022-5524
Abstract:
Add to Library
Authors:
Zhaoliang Huang
Xinghua Pang
Tingting Zhong
Chunshan Jin
Na Chen
Dennis Xia
Peng Zhang
Max Wang
Michelle Xia
Baiyong Li
Abstract 1446: Effect of PF-03475952, a potent and neutralizing CD44 antibody, on cancer cell apoptosis in vitro and metastasis in two orthotopic models
Publication Year: 2010
DOI: https://doi.org/10.1158/1538-7445.am10-1446
Abstract:
Add to Library
Authors:
Yuli Wang
Jean Wang
Gary Li
Amy Jackson-Fisher
Brett H. Simmons
Eugenia Kraynov
Baiyong Li
David Pocalyko
Found 35 results in 0.072 seconds
What is Boolean Searches
Including any of the words AND
, OR
, or NOT
in any of your searches will enable
boolean search. Those words must be UPPERCASE . You can use this in all searches, including using
the search parameter, and using search filters.
This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks.
Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and
stop-word removal (be sure to use double quotation marks — "
). Using parentheses will specify order of
operations for the boolean operators. Words that are not separated by one of the boolean operators will be
interpreted as AND
.
Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as
title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard
and fuzzy searches using *
, ?
or ~
are not allowed; these characters will be
removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as
described above, including stemming and removal of stop words.
Example Search
Search for works that mention "elmo"
and "sesame street"
, but not the words
"cookie"
or "monster"
:
"elmo" AND "sesame street" NOT "cookie" NOT "monster"